Replies to post #38234 on Biotech Values

[rfj1862]

DVAX

I sold my DVAX today. That makes two round trips. I'm waiting for $8.50 or so to repurchase.

I think that the Heplisav results move DVAX close to the top of any list of acquisition targets. If the Tolamba results are positive, I predict this company will be acquired shortly thereafter.

[ajs]

Do you have an estimate of annual sells for DVAX 3 to 5 years down the road?

TIA.